Skip to main content
PMC home page
Gut logoLink to Gut
. 2001 Dec;49(6):790–794. doi: 10.1136/gut.49.6.790

A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn's disease

K Leiper 1, J Woolner 1, M Mullan 1, T Parker 1, M van der Vliet 1, S Fear 1, J Rhodes 1, J Hunter 1
PMCID: PMC1728544  PMID: 11709513

Abstract

BACKGROUND—Polymeric feeds have shown variable efficacy in active Crohn's disease (CD) with remission rates from 36% to 82%. Meta-analyses of elemental, peptide, and whole protein feeds have shown a strong negative correlation between remission rate in CD and the long chain triglyceride (LCT) content of the feed. We performed a randomised controlled double blind trial in patients with active CD comparing two single whole protein feeds with LCT supplying 5% or 30% of the total energy.
METHODS—Fifty four patients with active CD (Crohn's disease activity index (CDAI) >200, serum C reactive protein (CRP) 10 mg/l) were randomised to a high or low LCT feed for three weeks. The total amount of energy supplied by fat was identical in the two feeds. Remission was defined as a CDAI ⩽150 and response as a fall in CDAI of ⩾70 or a CRP <10 mg/l.
RESULTS—Overall remission rate by intention to treat was 26% for the low LCT feed and 33% for the high LCT feed (p=0.38). Response was achieved in 33% with the low LCT and in 52% with the high LCT feed (p=0.27). CRP <10 mg/l was achieved in 30% in the low LCT and 33% in the high LCT group (p=0.99). Thirty nine per cent (21/54) of patients withdrew before three weeks because of inability to tolerate the diet. Excluding patients unable to tolerate the diet, remission rates were 46% for low LCT and 45% for high LCT (p=0.99).
DISCUSSION—This trial has shown no difference in the effect of low and high LCT whole protein feeds in active CD. The previously reported correlation between LCT content of diet and response in active CD is unlikely to be due to LCT itself and may be due to some other component of high LCT feeds.


Keywords: Crohn's disease therapy; polymeric feeds; dietary fat

Full Text

The Full Text of this article is available as a PDF (152.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Individual patient Crohn's disease activity index (CDAI) response to low (A) and high (B) long chain triglyceride containing polymeric feeds.

Figure 2  .

Figure 2  

Open in a new tab

Individual patient serum C reactive protein (CRP) response to low (A) and high (B) long chain triglyceride containing polymeric feeds.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Belluzzi A., Brignola C., Campieri M., Pera A., Boschi S., Miglioli M. Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med. 1996 Jun 13;334(24):1557–1560. doi: 10.1056/NEJM199606133342401. [DOI] [PubMed] [Google Scholar]
  2. Best W. R., Becktel J. M., Singleton J. W., Kern F., Jr Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976 Mar;70(3):439–444. [PubMed] [Google Scholar]
  3. Endres S., Ghorbani R., Kelley V. E., Georgilis K., Lonnemann G., van der Meer J. W., Cannon J. G., Rogers T. S., Klempner M. S., Weber P. C. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med. 1989 Feb 2;320(5):265–271. doi: 10.1056/NEJM198902023200501. [DOI] [PubMed] [Google Scholar]
  4. Fernández-Bañares F., Cabré E., González-Huix F., Gassull M. A. Enteral nutrition as primary therapy in Crohn's disease. Gut. 1994 Jan;35(1 Suppl):S55–S59. doi: 10.1136/gut.35.1_suppl.s55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Giaffer M. H., North G., Holdsworth C. D. Controlled trial of polymeric versus elemental diet in treatment of active Crohn's disease. Lancet. 1990 Apr 7;335(8693):816–819. doi: 10.1016/0140-6736(90)90936-y. [DOI] [PubMed] [Google Scholar]
  6. González-Huix F., de León R., Fernández-Bañares F., Esteve M., Cabré E., Acero D., Abad-Lacruz A., Figa M., Guilera M., Planas R. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut. 1993 Jun;34(6):778–782. doi: 10.1136/gut.34.6.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harvey R. F., Bradshaw J. M. A simple index of Crohn's-disease activity. Lancet. 1980 Mar 8;1(8167):514–514. doi: 10.1016/s0140-6736(80)92767-1. [DOI] [PubMed] [Google Scholar]
  8. Irvine E. J., Feagan B., Rochon J., Archambault A., Fedorak R. N., Groll A., Kinnear D., Saibil F., McDonald J. W. Quality of life: a valid and reliable measure of therapeutic efficacy in the treatment of inflammatory bowel disease. Canadian Crohn's Relapse Prevention Trial Study Group. Gastroenterology. 1994 Feb;106(2):287–296. doi: 10.1016/0016-5085(94)90585-1. [DOI] [PubMed] [Google Scholar]
  9. James W. P. Basal metabolic rate: comments on the new equations. Hum Nutr Clin Nutr. 1985;39 (Suppl 1):92–96. [PubMed] [Google Scholar]
  10. Khoshoo V., Reifen R., Neuman M. G., Griffiths A., Pencharz P. B. Effect of low- and high-fat, peptide-based diets on body composition and disease activity in adolescents with active Crohn's disease. JPEN J Parenter Enteral Nutr. 1996 Nov-Dec;20(6):401–405. doi: 10.1177/0148607196020006401. [DOI] [PubMed] [Google Scholar]
  11. Lorenz-Meyer H., Bauer P., Nicolay C., Schulz B., Purrmann J., Fleig W. E., Scheurlen C., Koop I., Pudel V., Carr L. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol. 1996 Aug;31(8):778–785. doi: 10.3109/00365529609010352. [DOI] [PubMed] [Google Scholar]
  12. Middleton S. J., Rucker J. T., Kirby G. A., Riordan A. M., Hunter J. O. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr. 1995 Aug;14(4):229–236. doi: 10.1016/s0261-5614(95)80004-2. [DOI] [PubMed] [Google Scholar]
  13. Miura S., Tsuzuki Y., Hokari R., Ishii H. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol. 1998 Dec;13(12):1183–1190. [PubMed] [Google Scholar]
  14. Morrow W. J., Homsy J., Swanson C. A., Ohashi Y., Estes J., Levy J. A. Dietary fat influences the expression of autoimmune disease in MRL/lpr/lpr mice. Immunology. 1986 Nov;59(3):439–443. [PMC free article] [PubMed] [Google Scholar]
  15. Nagel E., Schattenfroh S., Bühner S., Bartels M., Guthy E., Pichlmayr R. Tierexperimentelle Untersuchungen zu ultrastrukturellen Veränderungen der Lamina propria des Ileums durch Nahrungsfette und deren Vergleich zur Zytopathologie beim Morbus Crohn. Z Gastroenterol. 1993 Dec;31(12):727–734. [PubMed] [Google Scholar]
  16. O'Moráin C., Segal A. W., Levi A. J. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J (Clin Res Ed) 1984 Jun 23;288(6434):1859–1862. doi: 10.1136/bmj.288.6434.1859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Raouf A. H., Hildrey V., Daniel J., Walker R. J., Krasner N., Elias E., Rhodes J. M. Enteral feeding as sole treatment for Crohn's disease: controlled trial of whole protein v amino acid based feed and a case study of dietary challenge. Gut. 1991 Jun;32(6):702–707. doi: 10.1136/gut.32.6.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rigaud D., Cosnes J., Le Quintrec Y., René E., Gendre J. P., Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental versus polymeric diet. Gut. 1991 Dec;32(12):1492–1497. doi: 10.1136/gut.32.12.1492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Royall D., Jeejeebhoy K. N., Baker J. P., Allard J. P., Habal F. M., Cunnane S. C., Greenberg G. R. Comparison of amino acid v peptide based enteral diets in active Crohn's disease: clinical and nutritional outcome. Gut. 1994 Jun;35(6):783–787. doi: 10.1136/gut.35.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sadeghi S., Wallace F. A., Calder P. C. Dietary lipids modify the cytokine response to bacterial lipopolysaccharide in mice. Immunology. 1999 Mar;96(3):404–410. doi: 10.1046/j.1365-2567.1999.00701.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Saverymuttu S., Hodgson H. J., Chadwick V. S. Controlled trial comparing prednisolone with an elemental diet plus non-absorbable antibiotics in active Crohn's disease. Gut. 1985 Oct;26(10):994–998. doi: 10.1136/gut.26.10.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. van Hees P. A., van Elteren P. H., van Lier H. J., van Tongeren J. H. An index of inflammatory activity in patients with Crohn's disease. Gut. 1980 Apr;21(4):279–286. doi: 10.1136/gut.21.4.279. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES